Single-center study utilizing C 2 level as monitoring tool in de novo renal transplant recipients treated with neoral

By Keshavamurthy M.   Al Ahmadi I.   Mohammed Raza S.   Baynton R.   Al Meshari K.   Al Shaibani K.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3112-3114

Elsevier

Access to resources Recommend Favorite

Benefits of cyclosporine microemulsion (Neoral) C 2 monitoring are sustained at 1 year in de novo liver transplant recipients

By Lake J.R.   Neo-INT-06 Study Group  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3092-3093

Elsevier

Access to resources Recommend Favorite

C 2 monitoring and absorption profiling of cyclosporine for optimization of immunosuppressive therapy in pediatric renal transplant recipients

By Weber L.T.   Shipkova M.   Armstrong V.W.   Mehls O.   Oellerich M.   Tonshoff B.   German Study Group Pediatric Renal Transplantation  

Transplantation Proceedings, Vol. 35, Iss. 6, 2003-09 ,pp. : 2128-2130

Elsevier

Access to resources Recommend Favorite

Neoral (cyclosporine) C 2 monitoring in renal transplant recipients: a single-center experience in Asia

By Wong H.-S.   Morad Z.  

Transplantation Proceedings, Vol. 35, Iss. 1, 2003-02 ,pp. : 230-231

Elsevier

Access to resources Recommend Favorite

Study of a new generic cyclosporine, Consupren, in de novo renal transplant recipients

By Zafar M.N.   Ahmed E.   Alam A.   Akhtar F.   Zafar H.   Hashmi A.   Naqvi A.   Rizvi A.  

Transplantation Proceedings, Vol. 34, Iss. 6, 2002-09 ,pp. : 2480-2481

Elsevier

Access to resources Recommend Favorite